Flora to Host CBD and the Global Market Webinar Today

Today, Flora Growth is holding a webinar with CEO Luis Merchan at 1 pm EST where he will discuss the Company’s perspective on CBD and the Global Market. Register here.

MIAMI & TORONTO--(BUSINESS WIRE)--$FLGC--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products, will hold a webinar today, February 11^th, at 1:00 p.m. ET. All those interested in attending are encouraged to register using the link below. Questions can be submitted in advance of the event, upon registration.

This webinar will be the first of our State of Play series. During this CBD and the Global Market webinar, Luis Merchan will explore the opportunities and challenges that lie ahead for the CBD industry in North America, Latin America and the EU.

Registration Link:
https://us02web.zoom.us/webinar/register/WN_NTh2FsXuSkCQtShnI0fRuQ

About Flora Growth Corp.

Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; Flora’s ability to execute on its research and pharmaceutical strategies; the results of Flora’s research; the collaboration with third parties; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

Investor Relations:
Evan Veryard
evan.veryard@floragrowth.com

Public Relations:
Cassandra Dowell
+1 (858) 264-6600
flora@cmwmedia.com